Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/182748
Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background and Objectives To demonstrate that an analog (SGE-301) of a brain-derived cholesterol metabolite, 24(S)- hydroxycholesterol, which is a selective positive allosteric modulator (PAM) of NMDA re- ceptors (NMDARs), is able to reverse the memory and synaptic alterations caused by CSF from patients with anti-NMDAR encephalitis in an animal model of passive transfer of antibodies. Methods Four groups of mice received (days 1-14) patients' or controls' CSF via osmotic pumps connected to the cerebroventricular system and from day 11 were treated with daily sub- cutaneous injections of SGE-301 or vehicle (no drug). Visuospatial memory, locomotor activity (LA), synaptic NMDAR cluster density, hippocampal long-term potentiation (LTP), and paired-pulse facilitation (PPF) were assessed on days 10, 13, 18, and 26 using reported techniques. Results On day 10, mice infused with patients' CSF, but not controls' CSF, presented a significant visuospatial memory deficit, reduction of NMDAR clusters, and impairment of LTP, whereas LA and PPF were unaffected. These alterations persisted until day 18, the time of maximal deficits in this model. In contrast, mice that received patients' CSF but from day 11 were treated with SGE-301 showed memory recovery (day 13), and on day 18, all paradigms (memory, NMDAR clusters, and LTP) had reversed to values similar to those of controls. On day 26, no differences were observed among experimental groups. Discussion An oxysterol biology-based PAM of NMDARs is able to reverse the synaptic and memory deficits caused by CSF from patients with anti-NMDAR encephalitis. These findings suggest a novel adjuvant treatment approach that deserves future clinical evaluation.
Matèries (anglès)
Citació
Citació
RADOSEVIC, Marija, PLANAGUMÀ, Jesús, MANNARA, Francesco, MELLADO, Araceli, AGUILAR, Esther, SABATER BAUDET, Lidia, LANDA MEDRANO, Jon, GARCÍA SERRA, Anna, MAUDES, Estibaliz, GASULL CASANOVA, Xavier, LEWIS, Mike, DALMAU OBRADOR, Josep. Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice. _Neurology. Neuroimmunology & Neuroinflammation_. 2021. Vol. 9, núm. 1, pàgs. e1122. [consulta: 20 de gener de 2026]. ISSN: 2332-7812. [Disponible a: https://hdl.handle.net/2445/182748]